Diet, Exercise and Cardiovascular Health - Effects of Chinese Heart Healthy Diet on Blood Pressure Among People With High Cardiovascular Risk: a Parallel, Multicenter, Single-blind, Randomized Controlled Feeding Trial
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 265
- 试验地点
- 6
- 主要终点
- The change on systolic blood pressure among people at high risk of cardiovascular and cerebrovascular diseases
研究概览
简要总结
The DECIDE - Diet (Diet, ExerCIse and carDiovascular hEalth - Chinese Heart Healthy Diet for People With High Cardiovascular Risk in China) is to evaluate the effects of CHH-diet in reducing blood pressure in Chinese people with high cardiovascular risk. The study will recruit 360 adults people from 4 centers in China. All eligible participants will participate in a 1-week run-in phase in which they are fed the usual Chinese diet. Participants who pass the run-in phase will be randomly assigned 1:1 to receive CHH-diet or usual diet with the use of a central concealed randomization procedure (simple randomization), stratified by center and batch.
The intervention will last 28 days. Primary outcome will be the change in systolic blood pressure. The secondary outcomes include the differences between the two groups in the changes of diastolic blood pressure, total cholesterol, fasting blood glucose, 10-year CVD risk, gut microbial community and food preference score.
详细描述
The Chinese Heart Healthy Diet (CHH-diet) is a study in the DECIDE project (Diet, ExerCIse and carDiovascular hEalth), which includes five studies. The others are DECIDE - Exercise, DECIDE - Salt in Elderly, DECIDE - Obesity in Children, and DECIDE - Smart Living. The primary aim of this study is to evaluate the effects of CHH-diet in reducing blood pressure in Chinese adults with high cardiovascular risk. The corresponding null hypothesis is the mean systolic blood pressure of participants in CHH-diet group is equal to the mean systolic blood pressure of those in usual diet group. The secondary aims of this study are: 1) to evaluate the effect of CHH-diet on reducing the blood lipid, blood glucose and overall risk of cardiovascular and cerebrovascular diseases; 2) the influence of different cuisines on the intervention effect; 3) the influence of baseline blood pressure, blood glucose and lipid levels on the intervention effect; 4) the difference of the food preference between the two groups; 5) the effect of CHH-diet on intestinal flora, and the influence of intestinal flora on the effect of CHH-diet on blood pressure, fasting blood glucose and blood lipids.
Potential participants will be evaluated for eligibility at each center located in cities accordance with the four cuisines: Qingdao and Beijing (Shandong cuisine), Shanghai (Huaiyang cuisine), Guangzhou (Cantonese cuisine), and Chengdu (Szechuan cuisine). Two screening visits will be performed to identify eligible participants. At the first visit, participants will be asked several key questions about inclusion and exclusion criteria. At the second visit, a full questionnaire and measurement will be conducted to screen eligible participants. All eligible participants will participate in a 1-week run-in phase in which they will be fed with the usual diet in urban China. A participant will be excluded if failing to consume more than three meals for any reason. Participants who pass the run-in phase will be re-check the inclusion and exclusion criteria and then assigned 1:1 to receive CHH-diet or usual diet with the use of a central concealed randomization procedure (simple randomization), stratified by center and batch after the each baseline survey completed. At each center, participants will enter the randomization phase through 3-4 batches according to the feeding capacity of each center.
Four different recipes of CHH-diet have been developed according to four local cuisines: Shandong cuisine (Qingdao and Beijing), Huaiyang cuisine (Shanghai), Cantonese cuisine (Guangzhou), and Chengdu (Szechuan cuisine), but the four different healthy recipes share the same nutrients targets. The control group will receive local usual diet with the similar 4-week menus as CHH-diet group, but their nutrients targets will be the same as run-in period. We will measure the actual intake of every meal for all participants during the whole study period to better estimate their nutrients intakes. All subjects will be advised to avoid outside food during the study period, and the information outside food should be reported if they eat.
Intake of foods and nutrients measurement: First, for each food/dish, raw food materials will be weighted after cleaning and before cooking. Then before the food served to the study participants it will also be weighted and recorded. After each meal, the leftover food from each participant will be measured and recorded as well. The average daily energy and dietary nutrient intake by each participants will be calculated using the China Food Composition (2nd Edition, volume 1).
The baseline data collection should be performed on the last two days of the run-in phase, which includes a questionnaire interview on demography, lifestyle and health behaviors, history of diseases, medication use (antihypertensive drugs, antidiabetic drugs, and lipid-lowering drugs), food preference; physical examinations (blood pressure, body weight & height, pulse rate); fasting blood tests (fasting glucose [FBG], total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], triglycerides, and serum potassium); spot urine tests (sodium, potassium, creatinine excretion); and fecal sample tests on gut microbial community. The same physical examinations, medication use, food preference, fasting blood tests, spot urine tests, physical examinations and fecal sample tests on microbiome will be repeated at the end of the trial with the same methods by staffs blinded to the intervention. In addition, blood pressure, body weight, medication use, food preference assessment will be assessed weekly during the trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
盲法说明
Due to the nature of dietary intervention, it is impractical to blind the cook, dietitian and the study staff who are responsible for preparing the foods and taking all measurements of the diets. However, staffs conducting the outcome assessments will be blinded to the allocation of intervention assignments. In addition, every effort is made to blind the study participants to their intervention assignment. First, they will not be told of their group assignment. Second, the two groups will consume their meals in separate rooms. Third, the same dishes using similar food materials will be used for both groups at the same meal.
入排标准
- 年龄范围
- 25 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women aged between 25 and 75 years old.
- •Systolic blood pressure (SBP) in 130-159 mm Hg, regardless of medication use;
- •Living in this community for the past six months and without intention to move out or go out in the next three months.
- •Agree to keep the current drugs and their dosages unchanged throughout the study.
- •Promised to follow the study diets for 5 weeks, and eat at least 18 study meals per week.
- •Able to eat at least one meal per day at local research center.
- •Signed Informed consent.
排除标准
- •Fasting blood glucose ≥10.0 mmol/L.
- •Total cholesterol ≥7.2 mmol/L.
- •Any changes in dose and/or type of oral medication for antihypertensive, hypoglycemic or lipid-lowering in the past 3 months.
- •Insulin injection within 1 month.
- •Unable or unwilling to change diet for any reason (such as vegetarians).
- •Relatives of researchers or administrators.
- •Family members already in this study.
- •Alcohol consumption ≥ 8 drinks per week for women, ≥15 drinks per week for men.
- •BMI ≥ 30Kg/m2, or currently losing weight.
- •Acute cardiovascular and cerebrovascular events within the past 6 months.
- •A history of chronic kidney disease, intestinal irritation or asthma.
- •Current or planned pregnancy prior to end of study, or breast-feeding.
- •Other serious chronic disease thought to interfere with the effect of the diet or with participation, such as tumor, chronic heart failure, severe depression or other mental disorders, immobilization or unable to move freely.
- •Allergy of common food (e.g. eggs, seafood, peanuts, etc.).
- •On special diet due to medical needs.
- •Acute diseases such as upper respiratory tract infection, fever, severe diarrhea.
- •Deafness, dementia, and inability to communicate.
结局指标
主要结局
The change on systolic blood pressure among people at high risk of cardiovascular and cerebrovascular diseases
时间窗: before and after 4-week intervention
Changes of systolic blood pressure in CHH-diet group compared with changes of usual diet group. Blood pressure will be taken 3 times within 24 hours at baseline and at the end of this trial: one in the morning between 8:00 am to 10:00 am, one in the afternoon between 2:00 pm to 4:00 pm, and one in the evening between 6:00 pm to 8:00 pm, respectively. In each time, 3 readings should be taken with at least one minute intervals. The mean of nine SBP readings will be used for the calculation of the changes in each participant.
次要结局
- The change on food preference scores among people at high risk of cardiovascular and cerebrovascular diseases(before and after 4-week intervention)
- The change on gut microbial community among people at high risk of cardiovascular and cerebrovascular diseases(before and after 4-week intervention)
- The change on the diastolic blood pressure among people at high risk of cardiovascular and cerebrovascular diseases(before and after 4-week intervention)
- The change on the serum total cholesterol among people at high risk of cardiovascular and cerebrovascular diseases(before and after 4-week intervention)
- The change on the fasting blood glucose among people at high risk of cardiovascular and cerebrovascular diseases(before and after 4-week intervention)
- The change on 10-year CVD risk among people at high risk of cardiovascular and cerebrovascular diseases(before and after 4-week intervention)
研究者
Yanfang Wang
Professor
Peking University
